Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause
NICE guidance
Summary (source: NICE)
Reference: HTG640
Type: NICE guidance
Published: 21 September 2022
Issued by: National Institute for Health and Care Excellence (NICE)
Full guidance: Read on nice.org.uk →
Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause is nice guidance HTG640, issued by the National Institute for Health and Care Excellence (NICE), which produces evidence-based recommendations for health and care in England.
Note: NICE guidance is published under a licence that applies to the UK and does not permit republication of the full text. This page provides the reference and a direct link to the official document. Read the full guidance on nice.org.uk →
Document official
Official summary published by the National Institute for Health and Care Excellence (nice.org.uk), last published 21 September 2022. Indicative information for healthcare professionals — refer to the full document. Reference and link only, per NICE licence.